100
Views
13
CrossRef citations to date
0
Altmetric
Original

Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma

HEMATOLOGY

, &
Pages 241-252 | Published online: 25 Mar 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria G Russeva & Gregory P Adams. (2004) Radioimmunotherapy with engineered antibodies. Expert Opinion on Biological Therapy 4:2, pages 217-231.
Read now

Articles from other publishers (12)

Ruoting Lin, Bowei Ma, Na Liu, Lu Zhang, Tiantian He, Xiongying Liu, Tongsheng Chen, Wenjuan Liu, Yongnan Liang, Tianfang Wang, Guoying Ni, Xiaosong Liu, Ning Yang, Jinhe Zhang & Jianwei Yuan. (2021) Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice. Annals of Nuclear Medicine 35:7, pages 811-822.
Crossref
Jens M. Theysohn, Stefan Müller, Jörg F. Schlaak, Judith Ertle, Thomas W. Schlosser, Andreas Bockisch & Thomas C. Lauenstein. (2012) Selective Internal Radiotherapy (SIRT) of Hepatic Tumors: How to Deal with the Cystic Artery. CardioVascular and Interventional Radiology 36:4, pages 1015-1022.
Crossref
Stanley J. Goldsmith. 2013. Nuclear Medicine Therapy. Nuclear Medicine Therapy 3 25 .
Li Li, Wei Wang, Xiangshang Xu, Hui Wang, Shujie Liao, Wei Li, Weina Zhang, Dan Liu, Bo Cao, Shixuan Wang, Keng Shen & Ding Ma. (2011) Aptamer-based radioimmunotherapy: the feasibility and prospect in cancer therapy. Journal of Radioanalytical and Nuclear Chemistry 290:2, pages 453-457.
Crossref
Stanley J. Goldsmith. (2010) Radioimmunotherapy of Lymphoma: Bexxar and Zevalin. Seminars in Nuclear Medicine 40:2, pages 122-135.
Crossref
Richard T. Kloos. (2009) Protecting Thyroid Cancer Patients from Untoward Effects of Radioactive Iodine Treatment. Thyroid 19:9, pages 925-928.
Crossref
John M. Pagel, Dana C. Matthews, Aimee Kenoyer, Donald K. Hamlin, Daniel S. Wilbur, Darrell R. Fisher, Ajay K. Gopal, Yukang Lin, Laura Saganic, Frederick R. Appelbaum & Oliver W. Press. (2009) Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia. Cancer Research 69:1, pages 185-192.
Crossref
Daniel A. Vallera, Andy R. Sicheneder, Elizabeth P. Taras, Martin W. Brechbiel, Jesse A. Vallera, Angela Panoskaltsis-Mortari & Linda J. Burns. (2007) Radiotherapy of CD45-Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled, PEGylated Anti-CD45 Antibody. Cancer Biotherapy and Radiopharmaceuticals 22:4, pages 488-500.
Crossref
Ajay Gopal. 2007. Nuclear Medicine Therapy. Nuclear Medicine Therapy 147 160 .
Sven de Vos. (2006) Historical Overview and Current State of Art in Diagnosis and Treatment of Hodgkin's and Non-Hodgkin's Lymphoma. PET Clinics 1:3, pages 203-217.
Crossref
Eneida R. Nemecek, Donald K. Hamlin, Darrell R. Fisher, Kenneth A. Krohn, John M. Pagel, Frederick R. Appelbaum, Oliver W. Press & Dana C. Matthews. (2005) Biodistribution of Yttrium-90–Labeled Anti-CD45 Antibody in a Nonhuman Primate Model. Clinical Cancer Research 11:2, pages 787-794.
Crossref
P. J. Blower. (2004) 30  Inorganic pharmaceuticals. Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem. 100, pages 633-658.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.